| Name | Title | Contact Details |
|---|
Katahdin Industries provides high-tolerance coating applications and specialized metal-finishing technology and services to the medical device and industrial markets through platform-focused subsidiaries including DCHN, Precision Coating, Medi-Solve Coatings and Sanford Process. Headquartered in Dedham, Mass., with operations in Woonsocket, R.I., Katahdin has earned an industry reputation as an innovative, high-quality supplier. Katahdin's technical and product development expertise, strong facilities and problem-solving culture have resulted in a track record of successful service performance for its customers. Each subsidiary is an expert provider of the services it offers. But mastery of the technology is only part of our competitive differentiation. Developing unique capabilities to handle specific applications, whether coating medical wire or finishing orthopedic equipment, allows us to provide these and other related services at a superior quality level and lower cost than other service providers. Katahdin's coating operations are conducted through Precision Coating Company, Inc., one of the largest plastics coating applicators in the world, specializing in PTFE and Teflon® coating applications in the medical device market. A separate co-located company, Precision Fabric, is a worldwide distributor and converter of PTFE-coated fabrics, tapes and belts. Specialized metal finishing services are conducted through DCHN, LLC, an industry leader in technical aluminum and titanium anodizing, electro-polish and passivation, and other related services. Sanford Process Corporation provides hard-coat anodizing solutions, as well as licenses the company's intellectual property, to a range of well-known OEMs and their prime subcontractors worldwide, with an increasing presence in Korea and China. Katahdin seeks to acquire expert service providers and formulators with a strong history of innovation, current facilities, dedicated customer service, and high-quality management. The company's acquisition strategy is flexible, offering the potential for owners to retain a stake in the business. By leveraging Katahdin's capabilities, acquired companies are able to increase growth and profitability by focusing on their customers and technology needs while expanding sales and marketing reach.
Telemedicine Solutions is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Thanks for being a member of our community. Here a few guidelines to make your experience engaging, beneficial and excellent for everyone. We are a respectful community Exactech exists to help people improve their quality of life and regain their independence if they`ve been injured or developed arthritic disease. We strive to manage this community the same way we operate our business – with a commitment to our values of Integrity, Passion, Teamwork, Accountability and Innovation – and we all have to do our part to respect fellow community members. Therefore, any comment or post that includes profanity, hate speech, personal attacks, false or misleading information, off-topic information, off-label claims, political endorsements, spam or third-party solicitations, or violates any of LinkedIn`s Terms and Conditions will be removed. Duplicate posts may also be removed from our page. Posts may be removed at any time and at our discretion. Users who engage in prohibited conduct may be blocked from posting in our community without prior notice.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.
Flosonics Medical is a venture-backed start-up that develops and commercializes wearable sensors, which improve clinical management of critically ill patients inside and outside of the hospital.